HYPOTHESIS: This study was designed to investigate the clinical and angiographic features and procedural outcomes of small-vessel stenting in a real-world experience during the transition era between drug-eluting stents (DES) and bare-metal stents (BMS). METHODS: Using one of the largest single-institutional cohorts, this study evaluated all patients who underwent percutaneous coronary intervention (PCI) from 2002 through 2005. Analysis was restricted to patients receiving a single stent or undergoing balloon-only angioplasty in a single anatomic site. Small-vessel stents (SVS) were defined as 2.00 to 2.75 mm and large-vessel stents (LVS) as 3.00 to 4.00 mm in diameter. RESULTS: A total of 19,580 stents were placed in 10,396 patients. Of 6208 patients fulfilling inclusion criteria, 1630 (26.3%) received SVS, and 4578 (73.7%) received LVS. The SVS group had more female (35.5% vs 26.3%, P < .001) and diabetic patients (27.9% vs 24.2%, P < .003) than the LVS group. Compared with LVS, SVS lesions were shorter (14.5 +/- 5.8 mm vs 15.7 +/- 6.4 mm, P < .0001) and more complex (66% vs 53% class B2/C lesions, P = .041). Indicators of procedural difficulty, including greater contrast volume, number of devices, total inflation time, and fluoroscopy time, were more commonly observed in the SVS group. After adjustment for confounding factors, the incidence of small treatment vessel diameter was significantly higher among the DES vs the BMS group (odds ratio [OR]: = 1.94, 95% confidence interval [CI]: 1.56-2.36). CONCLUSIONS: In addition to identifying distinct patient, lesion, and procedural performance characteristics, our study, one of the largest single-center experiences in small-vessel PCI, suggests that the availability of DES substantially increased the use of SVS, as opposed to balloon-only angioplasty, in this anatomically challenging setting. 2009 Wiley Periodicals, Inc.
HYPOTHESIS: This study was designed to investigate the clinical and angiographic features and procedural outcomes of small-vessel stenting in a real-world experience during the transition era between drug-eluting stents (DES) and bare-metal stents (BMS). METHODS: Using one of the largest single-institutional cohorts, this study evaluated all patients who underwent percutaneous coronary intervention (PCI) from 2002 through 2005. Analysis was restricted to patients receiving a single stent or undergoing balloon-only angioplasty in a single anatomic site. Small-vessel stents (SVS) were defined as 2.00 to 2.75 mm and large-vessel stents (LVS) as 3.00 to 4.00 mm in diameter. RESULTS: A total of 19,580 stents were placed in 10,396 patients. Of 6208 patients fulfilling inclusion criteria, 1630 (26.3%) received SVS, and 4578 (73.7%) received LVS. The SVS group had more female (35.5% vs 26.3%, P < .001) and diabeticpatients (27.9% vs 24.2%, P < .003) than the LVS group. Compared with LVS, SVS lesions were shorter (14.5 +/- 5.8 mm vs 15.7 +/- 6.4 mm, P < .0001) and more complex (66% vs 53% class B2/C lesions, P = .041). Indicators of procedural difficulty, including greater contrast volume, number of devices, total inflation time, and fluoroscopy time, were more commonly observed in the SVS group. After adjustment for confounding factors, the incidence of small treatment vessel diameter was significantly higher among the DES vs the BMS group (odds ratio [OR]: = 1.94, 95% confidence interval [CI]: 1.56-2.36). CONCLUSIONS: In addition to identifying distinct patient, lesion, and procedural performance characteristics, our study, one of the largest single-center experiences in small-vessel PCI, suggests that the availability of DES substantially increased the use of SVS, as opposed to balloon-only angioplasty, in this anatomically challenging setting. 2009 Wiley Periodicals, Inc.
Authors: Pierfrancesco Agostoni; Giuseppe G L Biondi-Zoccai; Gabriele L Gasparini; Maurizio Anselmi; Giorgio Morando; Marco Turri; Antonio Abbate; Eugene P McFadden; Corrado Vassanelli; Piero Zardini; Antonio Colombo; Patrick W Serruys Journal: Eur Heart J Date: 2005-01-28 Impact factor: 29.983
Authors: D Keane; A J Azar; P de Jaegere; W Rutsch; B de Bruyne; V Legrand; F Kiemeneij; P de Feyter; P van de Heuvel; Y Ozaki; M A Morel; P W Serruys Journal: Semin Interv Cardiol Date: 1996-12
Authors: Alfredo E Rodriguez; Maximo Rodriguez Alemparte; Carlos Fernandez Pereira; Cesar Federico Vigo; Alberto Sampaolesi; Victor Bernardi; Eugenio Marchand; Jorge Tronge; Igor F Palacios Journal: Am Heart J Date: 2005-07 Impact factor: 4.749
Authors: Gastón A Rodriguez-Granillo; Marco Valgimigli; Héctor M Garcia-Garcia; Andrew T L Ong; Jiro Aoki; Carlos A G van Mieghem; Keiichi Tsuchida; Georgios Sianos; Eugene McFadden; Willem J van der Giessen; Ron van Domburg; Pim de Feyter; Patrick W Serruys Journal: J Invasive Cardiol Date: 2005-08 Impact factor: 2.022
Authors: G R Dussaillant; G S Mintz; A D Pichard; K M Kent; L F Satler; J J Popma; S C Wong; M B Leon Journal: J Am Coll Cardiol Date: 1995-09 Impact factor: 24.094
Authors: T Akiyama; I Moussa; B Reimers; M Ferraro; Y Kobayashi; S Blengino; L Di Francesco; L Finci; C Di Mario; A Colombo Journal: J Am Coll Cardiol Date: 1998-11-15 Impact factor: 24.094